Do analysts rate HYPR or NTRB?

Hyperfine presently has a consensus price target of $1.78, indicating a potential upside of 21.32%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is HYPR or NTRB more profitable?

Hyperfine has a net margin of -226.88% compared to Nutriband's net margin of -448.25%. Hyperfine's return on equity of -98.83% beat Nutriband's return on equity. Company Net Margins Return on Equity Return on Assets Hyperfine -226.88% -98.83% -67.09% Nutriband -448.25% -112.64% -97.86%

Does the media refer more to HYPR or NTRB?

In the previous week, Hyperfine had 2 more articles in the media than Nutriband. MarketBeat recorded 3 mentions for Hyperfine and 1 mentions for Nutriband. Nutriband's average media sentiment score of 0.64 beat Hyperfine's score of 0.48 indicating that Nutriband is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nutriband 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend GUTS or NTRB?

Fractyl Health currently has a consensus target price of $5.40, indicating a potential upside of 552.96%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts plainly believe Fractyl Health is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has stronger valuation & earnings, GUTS or NTRB?

Nutriband has higher revenue and earnings than Fractyl Health. Nutriband is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,457.82 -$140.95M -$1.29 N/A Nutriband $1.80M 20.57 -$8.23M -$2.58 N/A

Is GUTS or NTRB more profitable?

Fractyl Health has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% Nutriband -448.25% -112.64% -97.86%

Do analysts recommend CVRX or NTRB?

CVRx presently has a consensus price target of $11.50, indicating a potential upside of 123.30%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00 Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better earnings and valuation, CVRX or NTRB?

Nutriband has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $59.07M 2.31 -$53.31M -$2.02 N/A Nutriband $1.80M 20.57 -$8.23M -$2.58 N/A

Is CVRX or NTRB more profitable?

CVRx has a net margin of -89.14% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -89.14% -120.76% -48.38% Nutriband -448.25% -112.64% -97.86%

Does the media favor CVRX or NTRB?

In the previous week, CVRx and CVRx both had 1 articles in the media. Nutriband's average media sentiment score of 0.64 beat CVRx's score of 0.00 indicating that Nutriband is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nutriband 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NTRB or MBOT?

Microbot Medical has a consensus target price of $6.63, indicating a potential upside of 264.01%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60

Does the media prefer NTRB or MBOT?

In the previous week, Microbot Medical had 1 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Nutriband. Microbot Medical's average media sentiment score of 0.67 beat Nutriband's score of 0.64 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutriband 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NTRB or RCEL?

Avita Medical has a consensus price target of $7.25, indicating a potential upside of 84.95%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than Nutriband. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nutriband 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Avita Medical 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Is NTRB or RCEL more profitable?

Avita Medical has a net margin of -62.67% compared to Nutriband's net margin of -448.25%. Avita Medical's return on equity of 0.00% beat Nutriband's return on equity. Company Net Margins Return on Equity Return on Assets Nutriband -448.25% -112.64% -97.86% Avita Medical -62.67% N/A -78.92%

Does the media refer more to NTRB or RCEL?

In the previous week, Nutriband and Nutriband both had 1 articles in the media. Nutriband's average media sentiment score of 0.64 beat Avita Medical's score of 0.00 indicating that Nutriband is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nutriband 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Nutriband (NTRB) Competitors

$3.05 -0.06 (-1.93%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$3.06 +0.01 (+0.36%)

As of 07:00 AM Eastern

Compare

NTRB vs. HYPR, GUTS, CVRX, MBOT, and RCEL

Should you buy Nutriband stock or one of its competitors? MarketBeat compares Nutriband with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nutriband include Hyperfine (HYPR), Fractyl Health (GUTS), CVRx (CVRX), Microbot Medical (MBOT), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

How does Nutriband compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

Hyperfine has a net margin of -226.88% compared to Nutriband's net margin of -448.25%. Hyperfine's return on equity of -98.83% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperfine	-226.88%	-98.83%	-67.09%
Nutriband	-448.25%	-112.64%	-97.86%

Nutriband has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.40M	12.80	-$35.57M	-$0.41	N/A
Nutriband	$1.80M	20.57	-$8.23M	-$2.58	N/A

Hyperfine has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

In the previous week, Hyperfine had 2 more articles in the media than Nutriband. MarketBeat recorded 3 mentions for Hyperfine and 1 mentions for Nutriband. Nutriband's average media sentiment score of 0.64 beat Hyperfine's score of 0.48 indicating that Nutriband is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hyperfine	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutriband	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hyperfine presently has a consensus price target of $1.78, indicating a potential upside of 21.32%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 19.7% of Nutriband shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by insiders. Comparatively, 52.2% of Nutriband shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Hyperfine beats Nutriband on 9 of the 16 factors compared between the two stocks.

How does Nutriband compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

Fractyl Health has a beta of 2.34, meaning that its share price is 134% more volatile than the broader market. Comparatively, Nutriband has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

Fractyl Health has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
Nutriband	-448.25%	-112.64%	-97.86%

Nutriband has higher revenue and earnings than Fractyl Health. Nutriband is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,457.82	-$140.95M	-$1.29	N/A
Nutriband	$1.80M	20.57	-$8.23M	-$2.58	N/A

In the previous week, Nutriband had 1 more articles in the media than Fractyl Health. MarketBeat recorded 1 mentions for Nutriband and 0 mentions for Fractyl Health. Nutriband's average media sentiment score of 0.64 beat Fractyl Health's score of 0.00 indicating that Nutriband is being referred to more favorably in the news media.

Company	Overall Sentiment
Fractyl Health	Neutral
Nutriband	Positive

Fractyl Health currently has a consensus target price of $5.40, indicating a potential upside of 552.96%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts plainly believe Fractyl Health is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

19.7% of Nutriband shares are held by institutional investors. 8.5% of Fractyl Health shares are held by company insiders. Comparatively, 52.2% of Nutriband shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Fractyl Health beats Nutriband on 9 of the 16 factors compared between the two stocks.

How does Nutriband compare to CVRx?

CVRx (NASDAQ:CVRX) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

CVRx has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Nutriband has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

Nutriband has lower revenue, but higher earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$59.07M	2.31	-$53.31M	-$2.02	N/A
Nutriband	$1.80M	20.57	-$8.23M	-$2.58	N/A

In the previous week, CVRx and CVRx both had 1 articles in the media. Nutriband's average media sentiment score of 0.64 beat CVRx's score of 0.00 indicating that Nutriband is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nutriband	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

75.3% of CVRx shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 18.9% of CVRx shares are held by insiders. Comparatively, 52.2% of Nutriband shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

CVRx has a net margin of -89.14% compared to Nutriband's net margin of -448.25%. Nutriband's return on equity of -112.64% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-89.14%	-120.76%	-48.38%
Nutriband	-448.25%	-112.64%	-97.86%

CVRx presently has a consensus price target of $11.50, indicating a potential upside of 123.30%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

CVRx beats Nutriband on 9 of the 16 factors compared between the two stocks.

How does Nutriband compare to Microbot Medical?

Nutriband (NASDAQ:NTRB) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

In the previous week, Microbot Medical had 1 more articles in the media than Nutriband. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Nutriband. Microbot Medical's average media sentiment score of 0.67 beat Nutriband's score of 0.64 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutriband	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nutriband has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$1.80M	20.57	-$8.23M	-$2.58	N/A
Microbot Medical	$105K	1,164.19	-$13.14M	-$0.26	N/A

Microbot Medical has a consensus target price of $6.63, indicating a potential upside of 264.01%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

19.7% of Nutriband shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 52.2% of Nutriband shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Nutriband has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to Nutriband's net margin of -448.25%. Microbot Medical's return on equity of -21.84% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-448.25%	-112.64%	-97.86%
Microbot Medical	N/A	-21.84%	-20.71%

Summary

Microbot Medical beats Nutriband on 11 of the 17 factors compared between the two stocks.

How does Nutriband compare to Avita Medical?

Nutriband (NASDAQ:NTRB) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Nutriband has higher earnings, but lower revenue than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Nutriband, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$1.80M	20.57	-$8.23M	-$2.58	N/A
Avita Medical	$71.61M	1.68	-$48.59M	-$1.57	N/A

19.7% of Nutriband shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 52.2% of Nutriband shares are owned by company insiders. Comparatively, 2.8% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Avita Medical has a net margin of -62.67% compared to Nutriband's net margin of -448.25%. Avita Medical's return on equity of 0.00% beat Nutriband's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-448.25%	-112.64%	-97.86%
Avita Medical	-62.67%	N/A	-78.92%

In the previous week, Nutriband and Nutriband both had 1 articles in the media. Nutriband's average media sentiment score of 0.64 beat Avita Medical's score of 0.00 indicating that Nutriband is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutriband	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nutriband has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

Avita Medical has a consensus price target of $7.25, indicating a potential upside of 84.95%. Given Avita Medical's stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Avita Medical beats Nutriband on 9 of the 15 factors compared between the two stocks.

Get Nutriband News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRB vs. The Competition

Export

Metric	Nutriband	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$37.81M	$2.96B	$6.45B	$12.38B
Dividend Yield	N/A	1.80%	2.69%	5.83%
P/E Ratio	-1.18	18.43	24.66	23.99
Price / Sales	20.57	324.90	526.33	107.23
Price / Cash	N/A	56.31	44.82	54.51
Price / Book	6.22	4.11	10.72	6.50
Net Income	-$8.23M	$64.45M	$3.56B	$336.88M
7 Day Performance	-0.33%	1.41%	0.94%	-0.16%
1 Month Performance	-16.21%	1.04%	0.36%	0.76%
1 Year Performance	-60.90%	23.88%	29.67%	28.49%

Nutriband Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRB Nutriband	0.6748 of 5 stars	$3.05 -1.9%	N/A	-60.5%	$37.81M	$1.80M	N/A	10	News Coverage
HYPR Hyperfine	2.6968 of 5 stars	$1.47 -1.3%	$1.78 +21.3%	+111.9%	$147.91M	$11.40M	N/A	190	News Coverage Positive News Gap Up
GUTS Fractyl Health	4.0882 of 5 stars	$0.83 -4.8%	$5.40 +553.0%	-48.6%	$137.87M	$90K	N/A	102	Gap Down
CVRX CVRx	1.9532 of 5 stars	$5.15 +6.0%	$11.50 +123.3%	-10.0%	$128.96M	$56.65M	N/A	160
MBOT Microbot Medical	2.7535 of 5 stars	$1.82 -1.6%	$6.63 +264.0%	-22.9%	$124.25M	N/A	N/A	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRB) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutriband (NTRB) Competitors

NTRB vs. HYPR, GUTS, CVRX, MBOT, and RCEL

How does Nutriband compare to Hyperfine?

Summary

How does Nutriband compare to Fractyl Health?

Summary

How does Nutriband compare to CVRx?

Summary

How does Nutriband compare to Microbot Medical?

Summary

How does Nutriband compare to Avita Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRB vs. The Competition

Nutriband Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nutriband (NTRB) Competitors

NTRB vs. HYPR, GUTS, CVRX, MBOT, and RCEL

How does Nutriband compare to Hyperfine?

Is HYPR or NTRB more profitable?

Which has stronger earnings and valuation, HYPR or NTRB?

Which has more volatility and risk, HYPR or NTRB?

Does the media refer more to HYPR or NTRB?

Do analysts rate HYPR or NTRB?

Do insiders and institutionals have more ownership in HYPR or NTRB?

Summary

How does Nutriband compare to Fractyl Health?

Which has more volatility and risk, GUTS or NTRB?

Is GUTS or NTRB more profitable?

Which has stronger valuation & earnings, GUTS or NTRB?

Does the media favor GUTS or NTRB?

Do analysts recommend GUTS or NTRB?

Do institutionals & insiders believe in GUTS or NTRB?

Summary

How does Nutriband compare to CVRx?

Which has more risk & volatility, CVRX or NTRB?

Which has better earnings and valuation, CVRX or NTRB?

Does the media favor CVRX or NTRB?

Do institutionals and insiders believe in CVRX or NTRB?

Is CVRX or NTRB more profitable?

Do analysts recommend CVRX or NTRB?

Summary

How does Nutriband compare to Microbot Medical?

Does the media prefer NTRB or MBOT?

Which has stronger valuation and earnings, NTRB or MBOT?

Do analysts prefer NTRB or MBOT?

Do institutionals & insiders believe in NTRB or MBOT?

Which has more risk and volatility, NTRB or MBOT?

Is NTRB or MBOT more profitable?

Summary

How does Nutriband compare to Avita Medical?

Which has better valuation and earnings, NTRB or RCEL?

Do institutionals & insiders have more ownership in NTRB or RCEL?

Is NTRB or RCEL more profitable?

Does the media refer more to NTRB or RCEL?

Which has more volatility & risk, NTRB or RCEL?

Do analysts prefer NTRB or RCEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRB vs. The Competition

Nutriband Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools